Evidence in favour
- Participation spans 9 named insiders rather than one filing source.
- The latest qualifying evidence is fresh, dated 09 Sep 2026.
Company insider dossier
10X Genomics Inc insider intelligence
TXG filings assessed for conviction, transaction quality, insider breadth, clustering, freshness, and price confirmation.
12/100
Concentrated distribution
97/100 confidence- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Health Information Services
- Latest evidence
- 9 Sep 2026
Investment committee read
Concentrated distribution
Priced common-share disposals are concentrated enough to warrant review, but they are not treated as a standalone bearish forecast.
Review exposure and filing contextDecision risks
- Qualifying disposal events outnumber acquisitions, although disposals receive a lower directional weight.
Price confirmation map
Weekly price with common-share events
Acquisitions and disposals are aligned to the nearest completed weekly bar.
Mar 2025Sep 2026
Weekly closeCommon-share acquisitionCommon-share disposal
Market confirmation
Price and trend context
- Latest close
- 68.59 USD
- One-week move
- +9.5%
- Four-week move
- +22.3%
- Fair-value gap
- +177.1%
- Trend signal
- Active
- Relative strength
- 136.6
Directional balance
Controlled event mix
0.0%acquisition
- Acquisition events
- 0
- Disposal events
- 31
- Net value
- -$12.7M
Cadence
Twelve-week filing pressure
Volume shows attention. Controlled events determine direction.
029 Jun
006 Jul
013 Jul
020 Jul
027 Jul
003 Aug
410 Aug
117 Aug
824 Aug
431 Aug
307 Sep
014 Sep
Named participants
Insider conviction by person
KOSARAJU, SRIDHARDirector500 events
MATEO, ALANDirector500 events
POPOVITS, KIMBERLY JDirector500 events
HINDSON, BENJAMIN J.Director, See Remarks252 events
TEICHMANN, SARAH A.Director252 events
SULIMAN, SHEHNAAZDirector204 events
TAICH, ADAMChief Financial Officer195 events
STUELPNAGEL, JOHN RDirector195 events
SAXONOV, SERGEDirector, Chief Executive Officer1213 events
Evidence quality
Security and transaction context
Role architecture
Who is participating
Transaction evidence
Auditable TXG filing ledger
Showing 1 to 30 of 39.
TAICH, ADAMChief Financial Officer
DisposalCommon equity
31428 sharesClass A Common Stock
$2.0MDirectional evidence
TAICH, ADAMChief Financial Officer
DisposalCommon equity
13754 sharesClass A Common Stock
$897.6KDirectional evidence
TAICH, ADAMChief Financial Officer
DisposalCommon equity
1206 sharesClass A Common Stock
$76.8KDirectional evidence
STUELPNAGEL, JOHN RDirector
DisposalCommon equity
7012 sharesClass A Common Stock
$425.3KDirectional evidence
STUELPNAGEL, JOHN RDirector
DisposalCommon equity
6814 sharesClass A Common Stock
$423.2KDirectional evidence
STUELPNAGEL, JOHN RDirector
DisposalCommon equity
6174 sharesClass A Common Stock
$386.5KDirectional evidence
SAXONOV, SERGEDirector, Chief Executive Officer
DisposalCommon equity
100 sharesClass A Common Stock
Not reportedContext evidence
SAXONOV, SERGEDirector, Chief Executive Officer
DisposalCommon equity
6494 sharesClass A Common Stock
$415.5KDirectional evidence
SAXONOV, SERGEDirector, Chief Executive Officer
DisposalCommon equity
3500 sharesClass A Common Stock
$220.6KDirectional evidence
SAXONOV, SERGEDirector, Chief Executive Officer
DisposalCommon equity
492 sharesClass A Common Stock
$31.9KDirectional evidence
SAXONOV, SERGEDirector, Chief Executive Officer
DisposalCommon equity
18545 sharesClass A Common Stock
$1.2MDirectional evidence
TAICH, ADAMChief Financial Officer
DisposalCommon equity
17166 sharesClass A Common Stock
$1.1MDirectional evidence
HINDSON, BENJAMIN J.Director, See Remarks
DisposalCommon equity
13818 sharesClass A Common Stock
$870.9KDirectional evidence
SULIMAN, SHEHNAAZDirector
DisposalCommon equity
1646 sharesClass A Common Stock
$105.3KDirectional evidence
SULIMAN, SHEHNAAZDirector
DisposalCommon equity
561 sharesClass A Common Stock
$35.2KDirectional evidence
SAXONOV, SERGEDirector, Chief Executive Officer
DisposalCommon equity
4000 sharesClass A Common Stock
Not reportedContext evidence
TEICHMANN, SARAH A.Director
DisposalCommon equity
2273 sharesClass A Common Stock
$129.9KDirectional evidence
TEICHMANN, SARAH A.Director
DisposalCommon equity
5278 sharesClass A Common Stock
$302.4KDirectional evidence
STUELPNAGEL, JOHN RDirector
DisposalCommon equity
17000 sharesClass A Common Stock
$978.9KDirectional evidence
STUELPNAGEL, JOHN RDirector
DisposalCommon equity
3000 sharesClass A Common Stock
$176.2KDirectional evidence
SAXONOV, SERGEDirector, Chief Executive Officer
DisposalCommon equity
9821 sharesClass A Common Stock
$346.8KDirectional evidence
SAXONOV, SERGEDirector, Chief Executive Officer
DisposalCommon equity
9991 sharesClass A Common Stock
$342.5KDirectional evidence
SAXONOV, SERGEDirector, Chief Executive Officer
DisposalCommon equity
8527 sharesClass A Common Stock
$283.9KDirectional evidence
SAXONOV, SERGEDirector, Chief Executive Officer
DisposalCommon equity
1661 sharesClass A Common Stock
$60.1KDirectional evidence
SULIMAN, SHEHNAAZDirector
DisposalCommon equity
5359 sharesClass A Common Stock
$174.6KDirectional evidence
SULIMAN, SHEHNAAZDirector
DisposalCommon equity
364 sharesClass A Common Stock
$12.1KDirectional evidence
KOSARAJU, SRIDHARDirector
AcquisitionCommon equity
8829 sharesClass A Common Stock
Not reportedContext evidence
MATEO, ALANDirector
AcquisitionCommon equity
8829 sharesClass A Common Stock
Not reportedContext evidence
POPOVITS, KIMBERLY JDirector
AcquisitionCommon equity
8829 sharesClass A Common Stock
Not reportedContext evidence
STUELPNAGEL, JOHN RDirector
AcquisitionCommon equity
8829 sharesClass A Common Stock
Not reportedContext evidence
Reading the dossier
Direction and confidence are separate
Conviction
The 0 to 100 score classifies deduplicated priced common-share evidence. Fifty is balanced or non-directional.
Confidence
Confidence rises with controlled event depth, named-insider breadth, fresh evidence, normalized values, and a longer observation span.
Disposals
Selling is not treated as the mirror image of buying. It carries less directional weight because taxes, diversification, compensation, and planned transactions can all create sales.
Price confirmation
The market chart tests whether the filing thesis is being confirmed or rejected by price, fair-value position, relative strength, and the current trend state.
Independent market research for education. This classification is not investment advice, a recommendation, a forecast, or an execution instruction.